Onesource Specialty Pharma Limited

DecreasedQuarterly

ONESOURCEPharmaceuticalsMarket Cap₹18K Cr

Stake

2.53% → 2.06%

SBI Life Insurance

Institution

The move

SBI Life Insurance decreased its stake in Onesource Specialty Pharma Limited from 2.53% to 2.06% by selling 535,750 shares. The shares are valued at ₹84.22 crore, calculated at a share price of ₹1571.30.

About Onesource Specialty Pharma Limited

Visit stock

A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.

About SBI Life Insurance

Visit investor

Joint venture between State Bank of India and BNP Paribas Cardif. Manages over Rs 4.7 lakh crore in total AUM with the flagship SBI Life Equity Fund alone holding over Rs 77,000 crore. One of India's largest private life insurers by AUM, with a multi-cap equity book deployed across ULIP and participating funds.

Get the next move the moment it happens.

Follow SBI Life Insurance and Onesource Specialty Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Onesource Specialty Pharma Limited shareholders SBI Life Insurance's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Onesource Specialty Pharma Limited

Amansa HoldingsDecreased

Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 3.47% to 1.86%, selling 1,841,289 shares. The value of the remaining shares is ₹334.8 Cr at ₹1571.30 apiece.

22 Jul 2026

FidelityNew position

Fidelity bought 20,20,423 shares of Onesource Specialty Pharma Limited, a 1.76% stake, worth ₹334.02 Cr at ₹1653.20 apiece.